1. BlueBird communication satellite is developed by which country?
[A] United States
[B] France
[C] China
[D] Russia
Show Answer
Correct Answer: A [United States]
Notes:
Indian Space Research Organisation (ISRO) plans to launch the Block 2 BlueBird communication satellite in 3–4 months. BlueBird is developed by U.S.-based AST SpaceMobile. The launch will take place from Satish Dhawan Space Centre, Sriharikota, using Launch Vehicle Mark-3 (LVM3), formerly GSLV-Mk III. This follows ISRO’s successful launch of NASA ISRO Synthetic Aperture Radar (NISAR) mission on July 30 using GSLV. BlueBird is an advanced American satellite designed for direct smartphone-to-satellite communication. It enables users to make calls and access internet directly from space without ground towers.
2. Which port has become the first Indian port to produce green hydrogen?
[A] Jawaharlal Nehru Port
[B] Cochin Port
[C] Paradip Port
[D] V. O. Chidambaranar (VOC) Port
Show Answer
Correct Answer: D [V. O. Chidambaranar (VOC) Port]
Notes:
V. O. Chidambaranar (VOC) Port, Thoothukudi, became the first Indian port to produce green hydrogen and achieve over 1 MW rooftop solar power generation. The announcement came during the Green Ports and Shipping Conference under NAVIC Cell-3 (Green Initiatives and Pollution Control), Ministry of Ports, Shipping and Waterways. The event is part of roadshows ahead of India Maritime Week 2025 in Mumbai, showcasing maritime sustainability and innovation. The conference discussed maritime decarbonisation, green financing, and policy frameworks for achieving India’s 2070 net-zero target.
3. Which institute has developed a new drug candidate, Compound 3b, to fight deadly drug-resistant bacteria?
[A] IIT Kanpur
[B] IIT Bombay
[C] IIT Roorkee
[D] IIT Ahmedabad
Show Answer
Correct Answer: C [IIT Roorkee]
Notes:
Recently, IIT Roorkee developed a new drug candidate, Compound 3b, to fight deadly drug-resistant bacteria. It targets KPC-2-producing Klebsiella pneumoniae, a World Health Organization (WHO) top-priority superbug. Compound 3b is a β-lactamase inhibitor that stops bacterial enzymes from breaking down antibiotics. It works with the antibiotic Meropenem, restoring its effectiveness against resistant infections. Preclinical lab and animal tests showed major infection reduction in lungs and safety to human cells. It marks a major step against antimicrobial resistance and boosts India’s role in global biomedical research.
4. Chagas disease, that was recently seen in news, is caused by which agent?
[A] Virus
[B] Bacteria
[C] Fungus
[D] Protozoa
Show Answer
Correct Answer: D [Protozoa]
Notes:
Recently, concern was raised that despite the huge human and economic toll of Chagas disease, investment in research and development of diagnostics, medicines, and vaccines remains disproportionately low. Chagas disease, or American trypanosomiasis, is caused by the protozoan parasite Trypanosoma cruzi. It spreads mainly through blood-sucking triatomine bugs, also called reduviid or “kissing bugs,” which often bite the face. Infection occurs when parasite-containing feces of the bug enter the body. It can also spread from mother to child, contaminated food or drinks, blood transfusions, organ transplants, or lab accidents. The disease is common in South America, Central America, and Mexico.
5. Which country announced the launch of Venera-D Venus mission?
[A] Russia
[B] China
[C] United States
[D] India
Show Answer
Correct Answer: A [Russia]
Notes:
Russia announced plans to launch the Venera-D mission to revisit Venus before 2036. Preliminary design work will begin in January 2026 under the new national space programme. The mission is being developed in collaboration with the Lavochkin Association. It will include a lander, a balloon probe, and an orbital spacecraft for comprehensive study of Venus. The design phase will take two years to complete. The launch is expected between 2034 and 2036, with the exact date decided after the design phase.
6. National Supercomputing Mission (NSM) is jointly implemented by which two government bodies?
[A] Ministry of Electronics and Information Technology and Department of Science and Technology
[B] Ministry of Finance and Ministry of Commerce and Industry
[C] Indian Space Research Organization and Department of Biotechnology
[D] Ministry of Defence and Ministry of Science and Technology
Show Answer
Correct Answer: A [Ministry of Electronics and Information Technology and Department of Science and Technology ]
Notes:
The National Supercomputing Mission (NSM) was launched in April 2015 by the Government of India with a budget of Rs.4,500 crore. Its vision is to achieve self-reliance and global leadership in supercomputing and provide state-of-the-art facilities to researchers. It is jointly implemented by the Ministry of Electronics and Information Technology (MeitY) and the Department of Science and Technology (DST) through Centre for Development of Advanced Computing (C-DAC), Pune and Indian Institute of Science (IISc), Bengaluru. As of August 2025, 37 supercomputers with 40 Petaflops capacity are installed across IITs, IISc, R&D labs and Tier-II/III cities. This information was submitted in the Lok Sabha today by Shri Jitin Prasada, Minister of State for Electronics and Information Technology.
7. What is the name of the newly developed hand-held, non-invasive brain injury diagnostic tool by ICMR and collaborators?
[A] NEUROSCAN
[B] BRAIN SAFE
[C] NEURONIC
[D] CEREBO
Show Answer
Correct Answer: D [CEREBO]
Notes:
CEREBO is a hand-held, portable, non-invasive brain injury diagnostic tool developed by Indian Council of Medical Research (ICMR), Medical Device & Diagnostics Mission Secretariat (MDMS), AIIMS Bhopal, NIMHANS Bengaluru, and Bioscan Research. It is designed for Traumatic Brain Injuries (TBIs) and detects intracranial bleeding and edema within a minute. The device is safe for infants and pregnant women and usable by paramedics and unskilled personnel. CEREBO provides colour-coded, radiation-free, cost-effective results where CT or MRI scans are inaccessible or delayed. It can be deployed in ambulances, trauma centres, rural clinics, and disaster response units.
8. Which district in Gujarat has been identified as a Mars-analogue site due to the presence of jarosite deposits?
[A] Banaskantha
[B] Junagadh
[C] Kutch
[D] Bhavnagar
Show Answer
Correct Answer: C [Kutch]
Notes:
Matanomadh, a remote village in Kutch district, Gujarat, may serve as a test bed for ISRO’s Mangalyaan-2 mission to Mars. Researchers from Space Applications Centre (SAC) Ahmedabad, Savitribai Phule Pune University (SPPU), and Birbal Sahni Institute of Palaeosciences, Lucknow dated jarosite mineral in Matanomadh to 55 million years (Paleocene period). Jarosite is a yellow, iron-rich sulphate mineral, similar to those found on Mars, indicating past water activity. The site allows field-analogue studies for Mars, including rover testing, drilling, geochemistry, and astrobiology research. The discovery can help decode Martian geology, past chemical interactions, and organic molecule trapping, aiding future Mars missions.
9. Acanthamoeba, recently emerging as a public health concern in Kerala, is what kind of organism?
[A] Free-living amoeba
[B] Bacteria
[C] Virus
[D] Fungus
Show Answer
Correct Answer: A [Free-living amoeba]
Notes:
Acanthamoeba, a free-living amoeba, is now a public health concern in Kerala causing eye (keratitis) and brain infections (amoebic meningoencephalitis). Acanthamoeba is a free-living amoeba found in water, soil, dust, swimming pools, hot tubs, and drinking water systems. It can also exist in humidifiers and heating, ventilation, and air conditioning (HVAC) systems. It causes infections in brain, skin, eyes, and sinuses. It enters through cuts, wounds, inhalation, or contact lens use.
10. Which organization developed India’s first indigenous multi-stage malaria vaccine (AdFalciVax)?
[A] Indian Council of Medical Research (ICMR)
[B] National Institute of Virology (NIV)
[C] All India Institute of Medical Sciences (AIIMS) New Delhi
[D] Serum Institute of India
Show Answer
Correct Answer: A [Indian Council of Medical Research (ICMR)]
Notes:
India has licensed Indian Immunologicals Limited, Techinvention Lifecare Private Limited, Panacea Biotec Limited, Biological E Limited, and Zydus Lifesciences for manufacturing its first indigenous multi-stage malaria vaccine (AdFalciVax). The vaccine was developed by Indian Council of Medical Research (ICMR) and partners. It targets Plasmodium falciparum before it enters the bloodstream to prevent transmission. The vaccine is affordable, stable, scalable, and effective for over 9 months at room temperature.